{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:20:53Z","timestamp":1794586853466,"version":"4.9.1"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ijcrp.2022.200143","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T12:09:14Z","timestamp":1659614954000},"page":"200143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Lipid oxidation in pathophysiology of atherosclerosis: Current understanding and therapeutic strategies"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7045-9106","authenticated-orcid":false,"given":"Rahagir","family":"Salekeen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu Nasim","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouzia","family":"Akhter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Morsaline","family":"Billah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Emdadul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2613-9177","authenticated-orcid":false,"given":"Kazi Mohammed","family":"Didarul Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijcrp.2022.200143_bib1","first-page":"116","article-title":"Basic pathogenic mechanisms of atherosclerosis","volume":"7","author":"Alfarisi","year":"2020","journal-title":"Egypt. J. Basic Appl. Sci."},{"issue":"1","key":"10.1016\/j.ijcrp.2022.200143_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.33590\/emj\/10314648","article-title":"Inflammation and thrombosis in coronary atherosclerosis: pathophysiologic mechanisms and clinical correlations","volume":"4","author":"Ambrose","year":"2019","journal-title":"Eur. Med. J."},{"issue":"1","key":"10.1016\/j.ijcrp.2022.200143_bib3","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"Issue 8","key":"10.1016\/j.ijcrp.2022.200143_bib4","first-page":"927","article-title":"Atherosclerosis: process, indicators, risk factors and new hopes","volume":"5","author":"Rafieian-Kopaei","year":"2014","journal-title":"Int. J. Prev. Med."},{"issue":"1","key":"10.1016\/j.ijcrp.2022.200143_bib5","first-page":"60","article-title":"Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease","volume":"1","author":"Badimon","year":"2012","journal-title":"Eur. Heart J.: Acute Cardiovascular Care"},{"issue":"3","key":"10.1016\/j.ijcrp.2022.200143_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/antiox8030072","article-title":"Measurement and clinical significance of lipid peroxidation as a biomarker of oxidative stress: oxidative stress in diabetes, atherosclerosis, and chronic inflammation","volume":"8","author":"Ito","year":"2019","journal-title":"Antioxidants"},{"key":"10.1016\/j.ijcrp.2022.200143_bib7","first-page":"524","article-title":"The changing landscape of atherosclerosis","volume":"vol. 592","author":"Libby","year":"2021"},{"issue":"6","key":"10.1016\/j.ijcrp.2022.200143_bib8","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1194\/jlr.R400001-JLR200","article-title":"The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL","volume":"45","author":"Navab","year":"2004","journal-title":"JLR (J. Lipid Res.)"},{"key":"10.1016\/j.ijcrp.2022.200143_bib9","first-page":"315","article-title":"Immunity and inflammation in atherosclerosis","volume":"vol. 124","author":"Wolf","year":"2019"},{"key":"10.1016\/j.ijcrp.2022.200143_bib10","article-title":"Oxidative stress-mediated atherosclerosis: mechanisms and therapies","volume":"vol. 8","author":"Yang","year":"2017"},{"key":"10.1016\/j.ijcrp.2022.200143_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jsps.2013.04.005","article-title":"Therapeutic approaches to drug targets in atherosclerosis Production and hosting by Elsevier","volume":"22","author":"Jamkhande","year":"2014","journal-title":"Saudi Pharmaceut. J."},{"key":"10.1016\/j.ijcrp.2022.200143_bib12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/TCRM.S179302","article-title":"New therapies for the treatment of heart failure: a summary of recent accomplishments","volume":"15","author":"Machaj","year":"2019","journal-title":"Therapeut. Clin. Risk Manag."},{"issue":"8","key":"10.1016\/j.ijcrp.2022.200143_bib13","doi-asserted-by":"crossref","first-page":"E176","DOI":"10.1161\/ATVBAHA.119.312578","article-title":"Myocardial infarction - from atherosclerosis to thrombosis: uncovering new diagnostic and therapeutic approaches","volume":"39","author":"Palasubramaniam","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"Issue 11","key":"10.1016\/j.ijcrp.2022.200143_bib14","article-title":"Arachidonic acid metabolites in cardiovascular and metabolic diseases","volume":"19","author":"Sonnweber","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijcrp.2022.200143_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/ars.2019.7955","article-title":"Lipid peroxidation in atherosclerotic cardiovascular diseases","volume":"34","author":"Gianazza","year":"2021","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ijcrp.2022.200143_bib16","article-title":"Recognition of oxidized lipids by macrophages and its role in atherosclerosis development","volume":"vol. 9","author":"Mushenkova","year":"2021"},{"issue":"4","key":"10.1016\/j.ijcrp.2022.200143_bib17","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1152\/physrev.00047.2003","article-title":"Role of oxidative modifications in atherosclerosis","volume":"84","author":"Stocker","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ijcrp.2022.200143_bib18","first-page":"147","article-title":"Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy","volume":"vol. 22","author":"Hartman","year":"2014"},{"key":"10.1016\/j.ijcrp.2022.200143_bib19","unstructured":"Kumar, K., Shair, G., Ranjodh, A., & Sanghera, S. (n.d.). Pharmacological Options in Atherosclerosis: A Review of the Existing Evidence. https:\/\/doi.org\/10.6084\/m9.figshare.7371020."},{"issue":"6","key":"10.1016\/j.ijcrp.2022.200143_bib20","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1515\/hsz-2018-0397","article-title":"The effects of oxidative stress on the development of atherosclerosis","volume":"400","author":"Khosravi","year":"2019","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ijcrp.2022.200143_bib21","article-title":"Design and immunological evaluation of a hybrid peptide as a potent TLR2 agonist by structure-based virtual screening","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.ijcrp.2022.200143_bib22","article-title":"Association of arachidonic acid-derived lipid mediators with subsequent onset of acute myocardial infarction in patients with coronary artery disease","volume":"10","author":"Huang","year":"2020","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ijcrp.2022.200143_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13459","article-title":"PCSK9 and atherosclerosis: looking beyond LDL regulation","volume":"51","author":"Ragusa","year":"2021","journal-title":"Eur. J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.ijcrp.2022.200143_bib24","doi-asserted-by":"crossref","first-page":"909","DOI":"10.5551\/jat.55400","article-title":"An update on the role of PCSK9 in atherosclerosis","volume":"27","author":"Yurtseven","year":"2020","journal-title":"J. Atherosclerosis Thromb."},{"key":"10.1016\/j.ijcrp.2022.200143_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.594441","article-title":"Proteolytic regulation of the lectin-like oxidized lipoprotein receptor LOX-1","volume":"7","author":"Mentrup","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.ijcrp.2022.200143_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-020-01009-4","article-title":"Research progress on alternative non-classical mechanisms of PCSK9 in atherosclerosis in patients with and without diabetes","volume":"19","author":"Tang","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ijcrp.2022.200143_bib27","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fcvm.2021.639727","article-title":"PCSK9 functions in atherosclerosis are not limited to plasmatic LDL-cholesterol regulation","volume":"8","author":"Luquero","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ijcrp.2022.200143_bib28","first-page":"598","article-title":"New insights into the role of iron in inflammation and atherosclerosis","volume":"vol. 47","author":"Cornelissen","year":"2019"},{"key":"10.1016\/j.ijcrp.2022.200143_bib29","article-title":"Lipid oxidation products on inflammation-mediated hypertension and atherosclerosis: a mini review","volume":"vol. 8","author":"Leong","year":"2021"},{"key":"10.1016\/j.ijcrp.2022.200143_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103189","article-title":"The associations of plasma phospholipid arachidonic acid with cardiovascular diseases: a Mendelian randomization study","volume":"63","author":"Zhang","year":"2021","journal-title":"EBioMedicine"},{"issue":"Issue 5","key":"10.1016\/j.ijcrp.2022.200143_bib31","article-title":"The diabetes mellitus\u2013atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation","volume":"21","author":"Poznyak","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijcrp.2022.200143_bib32","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.120.046464","article-title":"Hyperglycemia induces trained immunity in macrophages and their precursors and promotes atherosclerosis","volume":"144","author":"Edgar","year":"2021","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ijcrp.2022.200143_bib33","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41569-021-00606-4","article-title":"Hyperglycaemia-induced trained immunity promotes atherosclerosis","volume":"18","author":"Lim","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijcrp.2022.200143_bib34","first-page":"1447","article-title":"Insulin resistance and atherosclerosis: implications for insulin-sensitizing agents","volume":"vol. 40","author":"di Pino","year":"2019"},{"key":"10.1016\/j.ijcrp.2022.200143_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.738654","article-title":"Chronic stress A potential suspect Zero of atherosclerosis: a systematic review","volume":"8","author":"Meng","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ijcrp.2022.200143_bib36","first-page":"618","article-title":"Thrombosis formation on atherosclerotic lesions and plaque rupture","volume":"vol. 276","author":"Badimon","year":"2014"},{"key":"10.1016\/j.ijcrp.2022.200143_bib37","series-title":"Atherosclerosis Drugs Market Growth","year":"2020"},{"key":"10.1016\/j.ijcrp.2022.200143_bib38","series-title":"Atherosclerosis Therapeutics Market Insight and Trends 2031","year":"2021"},{"key":"10.1016\/j.ijcrp.2022.200143_bib39","series-title":"Global Atherosclerosis Therapeutics Market 2019-2023| Identification of New Drug Targets to Boost Growth","year":"2019"},{"key":"10.1016\/j.ijcrp.2022.200143_bib40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000360568","article-title":"Potential peptides in atherosclerosis therapy","volume":"43","author":"Marleau","year":"2014","journal-title":"Cardiovasc. Issues Endocrinol."},{"issue":"8","key":"10.1016\/j.ijcrp.2022.200143_bib41","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","article-title":"Targeting inflammation in atherosclerosis \u2014 from experimental insights to the clinic","volume":"20","author":"Soehnlein","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.ijcrp.2022.200143_bib42","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1021\/acs.joc.7b00152","article-title":"Lipid peroxidation: kinetics, mechanisms, and products","volume":"82","author":"Zielinski","year":"2017","journal-title":"J. Org. Chem."},{"issue":"7","key":"10.1016\/j.ijcrp.2022.200143_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068070","article-title":"Association of mitochondrial genetic variation with carotid atherosclerosis","volume":"8","author":"Sobenin","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijcrp.2022.200143_bib44","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.atherosclerosis.2015.03.036","article-title":"Retinol binding protein 4 induces mitochondrial dysfunction and vascular oxidative damage","volume":"240","author":"Wang","year":"2015","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.ijcrp.2022.200143_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092714","article-title":"Peptides as therapeutic agents for inflammatory-related diseases","volume":"19","author":"la Manna","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.ijcrp.2022.200143_bib46","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/eurheartj\/eht466","article-title":"Natriuretic peptides in cardiovascular diseases: current use and perspectives","volume":"35","author":"Volpe","year":"2014","journal-title":"Eur. Heart J."},{"issue":"JAN","key":"10.1016\/j.ijcrp.2022.200143_bib47","first-page":"526","article-title":"The potential therapeutic application of peptides and peptidomimetics in cardiovascular disease","volume":"7","author":"Recio","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijcrp.2022.200143_bib48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.abb.2018.11.021","article-title":"Natural and synthetic peptides in the cardiovascular diseases: an update on diagnostic and therapeutic potentials","volume":"662","author":"Grieco","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.ijcrp.2022.200143_bib49","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00011-018-1208-x","article-title":"Antiinflammatory peptides: current knowledge and promising prospects","volume":"68","author":"Dadar","year":"2019","journal-title":"Inflamm. Res."},{"issue":"Issue 4","key":"10.1016\/j.ijcrp.2022.200143_bib50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41573-019-0053-0","article-title":"Advances in oral peptide therapeutics","volume":"19","author":"Drucker","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.ijcrp.2022.200143_bib51","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.bmc.2017.06.052","article-title":"Therapeutic peptides: historical perspectives, current development trends, and future directions","volume":"26","author":"Lau","year":"2018","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijcrp.2022.200143_bib52","doi-asserted-by":"crossref","DOI":"10.1007\/s10989-018-9682-0","article-title":"Target specific anticoagulant peptides: a review","volume":"24","author":"Syed","year":"2018","journal-title":"Int. J. Pept. Res. Therapeut."},{"key":"10.1016\/j.ijcrp.2022.200143_bib53","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.atherosclerosis.2021.06.903","article-title":"The emerging landscape of peptide-based inhibitors of PCSK9","volume":"330","author":"Tombling","year":"2021","journal-title":"Atherosclerosis"},{"issue":"16","key":"10.1016\/j.ijcrp.2022.200143_bib54","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.3390\/jcm10163571","article-title":"Apolipoprotein and LRP1-based peptides as new therapeutic tools in atherosclerosis","volume":"10","author":"Amaro","year":"2021","journal-title":"J. Clin. Med."},{"issue":"9","key":"10.1016\/j.ijcrp.2022.200143_bib55","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.drudis.2019.05.026","article-title":"Peptide-based protease inhibitors from plants","volume":"24","author":"Hellinger","year":"2019","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.ijcrp.2022.200143_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-014-0142-7","article-title":"Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists","volume":"13","author":"Saraiva","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ijcrp.2022.200143_bib57","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ebiom.2017.01.006","article-title":"Human neutrophil peptide 1 limits hypercholesterolemia-induced atherosclerosis by increasing hepatic LDL clearance","volume":"16","author":"Paulin","year":"2017","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.ijcrp.2022.200143_bib58","doi-asserted-by":"crossref","first-page":"394","DOI":"10.21037\/cdt.2018.12.08","article-title":"Cortistatin, a novel cardiovascular protective peptide","volume":"9","author":"Liang","year":"2019","journal-title":"Cardiovasc. Diagn. Ther."},{"issue":"11","key":"10.1016\/j.ijcrp.2022.200143_bib59","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.4049\/jimmunol.1800122","article-title":"Vasoactive intestinal peptide ameliorates acute myocarditis and atherosclerosis by regulating inflammatory and autoimmune responses","volume":"200","author":"Benitez","year":"2018","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.ijcrp.2022.200143_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068802","article-title":"An apolipoprotein A-I mimetic peptide designed with a reductionist approach stimulates reverse cholesterol transport and reduces atherosclerosis in mice","volume":"8","author":"Ditiatkovski","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijcrp.2022.200143_bib61","first-page":"1","article-title":"Antimicrobial and anti-inflammatory activities of three chensinin-1 peptides containing mutation of glycine and histidine residues","volume":"7","author":"Dong","year":"2017","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.ijcrp.2022.200143_bib62","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.bbapap.2008.07.004","article-title":"Development of novel peptide inhibitor of Lipoxygenase based on biochemical and BIAcore evidences","volume":"1784","author":"Somvanshi","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.ijcrp.2022.200143_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032521","article-title":"Structure based design and synthesis of peptide inhibitor of human LOX-12: in vitro and in vivo analysis of a novel therapeutic agent for breast cancer","volume":"7","author":"Singh","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ijcrp.2022.200143_bib64","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1017\/S0007114509991814","article-title":"Vasodilating dipeptide Trp-His can prevent atherosclerosis in apo E-deficient mice","volume":"103","author":"Matsui","year":"2010","journal-title":"Br. J. Nutr."},{"issue":"7","key":"10.1016\/j.ijcrp.2022.200143_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181748","article-title":"THPdb: database of FDA-approved peptide and protein therapeutics","volume":"12","author":"Usmani","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ijcrp.2022.200143_bib66","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00161.2011","article-title":"Soymorphin-5, a soy-derived \u03bc-opioid peptide, decreases glucose and triglyceride levels through activating adiponectin and PPAR\u03b1 systems in diabetic KKAy mice","volume":"302","author":"Yamada","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ijcrp.2022.200143_bib67","first-page":"1354","article-title":"Bioactivities, applications, safety, and health benefits of bioactive peptides from food and by-products: a review","author":"Zaky","year":"2022","journal-title":"Front. Nutr."},{"issue":"1","key":"10.1016\/j.ijcrp.2022.200143_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-59165-2","article-title":"PlantPepDB: a manually curated plant peptide database","volume":"10","author":"Das","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijcrp.2022.200143_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.lwt.2021.111521","article-title":"Characterization and identification of novel anti-inflammatory peptides from Baijiao sea bass (Lateolabrax maculatus)","volume":"147","author":"Chen","year":"2021","journal-title":"LWT"},{"key":"10.1016\/j.ijcrp.2022.200143_bib70","series-title":"Anti-inflammatory Activity of Peptides Derived from Millet Bran in Vitro and in Vivo","author":"He","year":"2022"},{"issue":"6","key":"10.1016\/j.ijcrp.2022.200143_bib71","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.3892\/ijmm.2015.2386","article-title":"Bioactive peptide from Pyropia yezoensis and its anti-inflammatory activities","volume":"36","author":"Lee","year":"2015","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.ijcrp.2022.200143_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-015-1149-y","article-title":"A potent anti-inflammatory peptide from the salivary glands of horsefly","volume":"8","author":"Wei","year":"2015","journal-title":"Parasites Vectors"},{"issue":"78","key":"10.1016\/j.ijcrp.2022.200143_bib73","doi-asserted-by":"crossref","first-page":"49194","DOI":"10.1039\/C7RA08304A","article-title":"Peptide GEQQQQPGM derived from rice \u03b1-globulin reduces the risk of atherosclerosis in hamsters by improving vascular endothelial cells injury","volume":"7","author":"Tong","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijcrp.2022.200143_bib74","series-title":"Citrus Fruits as Source of Novel Bioactive Peptides: In-Vitro and In-Silico Analysis of Atheroprotective Potentials","author":"Salekeen","year":"2022"},{"issue":"151439","key":"10.1016\/j.ijcrp.2022.200143_bib75","article-title":"Food-derived bioactive peptides on inflammation and oxidative stress","author":"Chakrabarti","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"1","key":"10.1016\/j.ijcrp.2022.200143_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-65782-8","article-title":"Kefir peptides alleviate high-fat diet-induced atherosclerosis by attenuating macrophage accumulation and oxidative stress in ApoE knockout mice","volume":"10","author":"Tung","year":"2020","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.ijcrp.2022.200143_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/biom11101458","article-title":"Antioxidant and anti-inflammatory properties of bioavailable protein hydrolysates from lupin-derived agri-waste","volume":"11","author":"Montserrat-de la Paz","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijcrp.2022.200143_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2020.100636","article-title":"Antioxidant and anti-inflammatory activity of peptides from foxtail millet (Setaria italica) prolamins in HaCaT cells and RAW264.7 murine macrophages","volume":"36","author":"Ji","year":"2020","journal-title":"Food Biosci."},{"issue":"1","key":"10.1016\/j.ijcrp.2022.200143_bib79","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/bcp.13002","article-title":"Milk-derived bioactive peptides and their health promoting effects: a potential role in atherosclerosis","volume":"83","author":"Marcone","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.ijcrp.2022.200143_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22060949","article-title":"Anti-inflammatory and antioxidant properties of peptides released from \u03b2-lactoglobulin by high hydrostatic pressure-assisted enzymatic hydrolysis","volume":"22","author":"Bamdad","year":"2017","journal-title":"Molecules : J. Synth. Chem. Nat. Prod. Chem."},{"key":"10.1016\/j.ijcrp.2022.200143_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.foodchem.2016.01.108","article-title":"In vitro antithrombotic activities of peanut protein hydrolysates","volume":"202","author":"Zhang","year":"2016","journal-title":"Food Chem."},{"key":"10.1016\/j.ijcrp.2022.200143_bib82","first-page":"992","article-title":"Cancer treatment by caryophyllaceae-type cyclopeptides","volume":"11","author":"Tehrani","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"D1","key":"10.1016\/j.ijcrp.2022.200143_bib83","first-page":"D148","article-title":"miRTarBase 2020: updates to the experimentally validated microRNA\u2013target interaction database","volume":"48","author":"Huang","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.ijcrp.2022.200143_bib84","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/CIRCRESAHA.115.306300","article-title":"MicroRNA regulation of atherosclerosis","volume":"118","author":"Feinberg","year":"2016","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.ijcrp.2022.200143_bib85","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/14656566.2018.1550071","article-title":"Mipomersen and its use in familial hypercholesterolemia","volume":"20","author":"Parham","year":"2019","journal-title":"Expet Opin. Pharmacother."},{"issue":"MAY","key":"10.1016\/j.ijcrp.2022.200143_bib86","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fgene.2019.00478","article-title":"The potential for microRNA therapeutics and clinical research","volume":"10","author":"Hanna","year":"2019","journal-title":"Front. Genet."},{"issue":"9","key":"10.1016\/j.ijcrp.2022.200143_bib87","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1161\/ATVBAHA.118.310227","article-title":"Impact of miRNA in atherosclerosis","volume":"38","author":"Lu","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"S2","key":"10.1016\/j.ijcrp.2022.200143_bib88","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1017\/S000711451200253X","article-title":"Food proteins as a source of bioactive peptides with diverse functions","volume":"108","author":"Rutherfurd-Markwick","year":"2012","journal-title":"Br. J. Nutr."},{"issue":"1","key":"10.1016\/j.ijcrp.2022.200143_bib89","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/mnfr.201100535","article-title":"Role of dietary proteins and peptides in cardiovascular disease","volume":"56","author":"Cam","year":"2012","journal-title":"Mol. Nutr. Food Res."},{"issue":"22","key":"10.1016\/j.ijcrp.2022.200143_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225547","article-title":"MicroRNAs as potential biomarkers in atherosclerosis","volume":"20","author":"Churov","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.ijcrp.2022.200143_bib91","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.3390\/jcm8122199","article-title":"MicroRNAs as therapeutic targets and clinical biomarkers in atherosclerosis","volume":"8","author":"Solly","year":"2019","journal-title":"J. Clin. Med."}],"container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487522000198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487522000198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T10:56:08Z","timestamp":1757415368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772487522000198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":91,"alternative-id":["S2772487522000198"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcrp.2022.200143","relation":{},"ISSN":["2772-4875"],"issn-type":[{"value":"2772-4875","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid oxidation in pathophysiology of atherosclerosis: Current understanding and therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Cardiovascular Risk and Prevention","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcrp.2022.200143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200143"}}